Olema Pharmaceuticals Inc (OLMA) Insider Trading
- $53,844,919.13
- $6,981,418.12
- March 28, 2024
- Cyrus Harmon
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 28, 2024 | Director | 20,000 | $10.97 | Sell | $219,400.00 | |
Feb. 29, 2024 | Director | 25,000 | $12.41 | Sell | $310,250.00 | |
Jan. 31, 2024 | Director | 25,000 | $12.23 | Sell | $305,750.00 | |
Dec. 6, 2023 | Major Shareholder | 100,000 | $11.60 | Buy | $1,160,000.00 | |
Nov. 30, 2023 | Director | 25,000 | $12.57 | Sell | $314,250.00 | |
Nov. 21, 2023 | CEO | 29,293 | $14.88 | Sell | $435,879.84 | |
Nov. 21, 2023 | Director | 4,192 | $14.86 | Sell | $62,293.12 | |
Nov. 21, 2023 | Insider | 7,461 | $14.84 | Sell | $110,721.24 | |
Nov. 8, 2023 | Insider | 200 | $17.61 | Sell | $3,522.00 | |
Nov. 3, 2023 | Insider | 541 | $17.51 | Sell | $9,472.91 | |
Nov. 2, 2023 | Director | 5,000 | $15.64 | Sell | $78,200.00 | |
Nov. 1, 2023 | Insider | 6,668 | $15.02 | Sell | $100,153.36 | |
Oct. 31, 2023 | Director | 25,000 | $12.05 | Sell | $301,250.00 | |
Sept. 29, 2023 | Director | 25,000 | $12.41 | Sell | $310,250.00 | |
Sept. 19, 2023 | Insider | 20,000 | $12.67 | Sell | $253,400.00 | |
Sept. 12, 2023 | Director | 1,505,932 | $9.84 | Buy | $14,818,370.88 | |
Sept. 5, 2023 | Director | 10,000 | $11.62 | Sell | $116,200.00 | |
Aug. 31, 2023 | Director | 15,000 | $9.36 | Sell | $140,400.00 | |
June 8, 2023 | Director | 10,000 | $6.30 | Sell | $63,000.00 | |
June 5, 2023 | Director | 5,000 | $6.04 | Sell | $30,200.00 | |
June 10, 2022 | Director | 200,000 | $4.03 | Buy | $806,000.00 | |
March 10, 2022 | Insider | 5,253 | $4.75 | Sell | $24,951.75 | |
Jan. 10, 2022 | Insider | 5,251 | $6.85 | Sell | $35,969.35 | |
Dec. 10, 2021 | Insider | 5,251 | $10.39 | Sell | $54,557.89 | |
Nov. 30, 2021 | Director | 739,675 | $9.39 | Buy | $6,945,548.25 | |
Nov. 29, 2021 | CTO | 400 | $24.76 | Sell | $9,904.00 | |
Oct. 19, 2021 | CTO | 12,000 | $27.98 | Sell | $335,760.00 | |
Oct. 14, 2021 | CEO | 5,000 | $30.47 | Sell | $152,350.00 | |
Oct. 11, 2021 | Insider | 5,251 | $27.90 | Sell | $146,502.90 | |
Sept. 27, 2021 | CEO | 1,085 | $30.07 | Sell | $32,625.95 | |
Sept. 20, 2021 | CTO | 12,000 | $26.30 | Sell | $315,600.00 | |
Sept. 10, 2021 | Insider | 5,251 | $29.38 | Sell | $154,274.38 | |
Sept. 1, 2021 | CEO | 871 | $30.05 | Sell | $26,173.55 | |
Aug. 19, 2021 | CTO | 12,000 | $24.97 | Sell | $299,640.00 | |
Aug. 10, 2021 | Insider | 5,251 | $25.71 | Sell | $135,003.21 | |
July 20, 2021 | CTO | 4,123 | $25.63 | Sell | $105,672.49 | |
July 12, 2021 | Insider | 5,251 | $26.51 | Sell | $139,204.01 | |
June 18, 2021 | CTO | 12,000 | $24.80 | Sell | $297,600.00 | |
June 10, 2021 | Insider | 5,251 | $29.72 | Sell | $156,059.72 | |
May 18, 2021 | Insider | 57,763 | $24.15 | Sell | $1,394,976.45 | |
Nov. 23, 2020 | Director | 1,160,000 | $19.00 | Buy | $22,040,000.00 | |
Nov. 23, 2020 | Major Shareholder | 425,000 | $19.00 | Buy | $8,075,000.00 |
Insiders are both buying and selling Olema Pharmaceuticals Inc stock.
The insider traders at Olema Pharmaceuticals Inc are: Cyrus Harmon, Kinney Horn, Sean Bohen, David C Myles, Bvf Partners L P/Il, Biocapital Advisors L Paradigm, G. Walmsley Graham, Naseem Zojwalla, and Cormorant Asset Management, Lp
The most active insider trader at Olema Pharmaceuticals Inc is Cyrus Harmon with 18 trades.
Cyrus Harmon has sold the most Olema Pharmaceuticals Inc stock with a total value of $3,835,019.61.
G. Walmsley Graham has bought the most Olema Pharmaceuticals Inc stock with a total value of $44,080,000.00.
The most recent insider trade for Olema Pharmaceuticals Inc was on March 28, 2024.
The single biggest insider buy for Olema Pharmaceuticals Inc was from G. Walmsley Graham with a total value of $22,040,000.00 on Nov. 23, 2020.
The single biggest insider sell for Olema Pharmaceuticals Inc was from Kinney Horn with a total value of $1,394,976.45 on May 18, 2021.